rs1801187

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004006.3(DMD):​c.5234G>A​(p.Arg1745His) variant causes a missense change. The variant allele was found at a frequency of 0.477 in 1,207,521 control chromosomes in the GnomAD database, including 96,016 homozygotes. There are 192,221 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1745C) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.38 ( 7187 hom., 12673 hem., cov: 22)
Exomes 𝑓: 0.49 ( 88829 hom. 179548 hem. )

Consequence

DMD
NM_004006.3 missense

Scores

1
7
7

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:18

Conservation

PhyloP100: 4.17

Publications

48 publications found
Variant links:
Genes affected
DMD (HGNC:2928): (dystrophin) This gene spans a genomic range of greater than 2 Mb and encodes a large protein containing an N-terminal actin-binding domain and multiple spectrin repeats. The encoded protein forms a component of the dystrophin-glycoprotein complex (DGC), which bridges the inner cytoskeleton and the extracellular matrix. Deletions, duplications, and point mutations at this gene locus may cause Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD), or cardiomyopathy. Alternative promoter usage and alternative splicing result in numerous distinct transcript variants and protein isoforms for this gene. [provided by RefSeq, Dec 2016]
DMD Gene-Disease associations (from GenCC):
  • Becker muscular dystrophy
    Inheritance: XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet
  • dilated cardiomyopathy 3B
    Inheritance: XL Classification: DEFINITIVE Submitted by: Ambry Genetics
  • Duchenne and Becker muscular dystrophy
    Inheritance: XL Classification: DEFINITIVE Submitted by: Myriad Women’s Health
  • Duchenne muscular dystrophy
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • progressive muscular dystrophy
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • familial isolated dilated cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • non-syndromic X-linked intellectual disability
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • symptomatic form of muscular dystrophy of Duchenne and Becker in female carriers
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=1.1590453E-5).
BP6
Variant X-32362879-C-T is Benign according to our data. Variant chrX-32362879-C-T is described in ClinVar as Benign. ClinVar VariationId is 94657.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.688 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DMDNM_004006.3 linkc.5234G>A p.Arg1745His missense_variant Exon 37 of 79 ENST00000357033.9 NP_003997.2 P11532

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DMDENST00000357033.9 linkc.5234G>A p.Arg1745His missense_variant Exon 37 of 79 1 NM_004006.3 ENSP00000354923.3 A0A075B6G3

Frequencies

GnomAD3 genomes
AF:
0.385
AC:
42289
AN:
109787
Hom.:
7190
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.0832
Gnomad AMI
AF:
0.421
Gnomad AMR
AF:
0.580
Gnomad ASJ
AF:
0.430
Gnomad EAS
AF:
0.710
Gnomad SAS
AF:
0.658
Gnomad FIN
AF:
0.513
Gnomad MID
AF:
0.396
Gnomad NFE
AF:
0.470
Gnomad OTH
AF:
0.419
GnomAD2 exomes
AF:
0.528
AC:
96466
AN:
182810
AF XY:
0.533
show subpopulations
Gnomad AFR exome
AF:
0.0726
Gnomad AMR exome
AF:
0.728
Gnomad ASJ exome
AF:
0.443
Gnomad EAS exome
AF:
0.735
Gnomad FIN exome
AF:
0.529
Gnomad NFE exome
AF:
0.477
Gnomad OTH exome
AF:
0.506
GnomAD4 exome
AF:
0.486
AC:
533313
AN:
1097681
Hom.:
88829
Cov.:
34
AF XY:
0.494
AC XY:
179548
AN XY:
363113
show subpopulations
African (AFR)
AF:
0.0666
AC:
1758
AN:
26390
American (AMR)
AF:
0.711
AC:
25021
AN:
35186
Ashkenazi Jewish (ASJ)
AF:
0.448
AC:
8686
AN:
19383
East Asian (EAS)
AF:
0.685
AC:
20687
AN:
30197
South Asian (SAS)
AF:
0.662
AC:
35836
AN:
54144
European-Finnish (FIN)
AF:
0.522
AC:
21154
AN:
40503
Middle Eastern (MID)
AF:
0.488
AC:
2017
AN:
4133
European-Non Finnish (NFE)
AF:
0.471
AC:
396310
AN:
841668
Other (OTH)
AF:
0.474
AC:
21844
AN:
46077
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
10169
20338
30506
40675
50844
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
13160
26320
39480
52640
65800
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.385
AC:
42276
AN:
109840
Hom.:
7187
Cov.:
22
AF XY:
0.394
AC XY:
12673
AN XY:
32130
show subpopulations
African (AFR)
AF:
0.0830
AC:
2522
AN:
30397
American (AMR)
AF:
0.581
AC:
5909
AN:
10172
Ashkenazi Jewish (ASJ)
AF:
0.430
AC:
1123
AN:
2614
East Asian (EAS)
AF:
0.711
AC:
2437
AN:
3427
South Asian (SAS)
AF:
0.655
AC:
1691
AN:
2581
European-Finnish (FIN)
AF:
0.513
AC:
2890
AN:
5629
Middle Eastern (MID)
AF:
0.395
AC:
85
AN:
215
European-Non Finnish (NFE)
AF:
0.470
AC:
24713
AN:
52634
Other (OTH)
AF:
0.415
AC:
622
AN:
1497
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
789
1577
2366
3154
3943
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
402
804
1206
1608
2010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.445
Hom.:
64748
Bravo
AF:
0.381
TwinsUK
AF:
0.479
AC:
1775
ALSPAC
AF:
0.472
AC:
1363
ESP6500AA
AF:
0.0806
AC:
309
ESP6500EA
AF:
0.477
AC:
3209
ExAC
AF:
0.516
AC:
62654

ClinVar

Significance: Benign
Submissions summary: Benign:18
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:8
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Feb 18, 2019
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: DMD c.5234G>A (p.Arg1745His) results in a non-conservative amino acid change located in a spectrin repeat (IPR018159) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.51 in 199355 control chromosomes, suggesting that it is the major allele and therefore benign. Six ClinVar submissions from clinical diagnostic laboratories (evaluation after 2014) cite the variant as benign (5x) and once as likely benign. Based on the evidence outlined above, the variant was classified as benign. -

Nov 20, 2013
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

May 11, 2016
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Apr 09, 2025
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 29, 2014
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Arg1745His in exon 37 of DMD: This variant is not expected to have clinical si gnificance because it has been identified in 48% (3209/6728) of European America n chromosomes by the NHLBI Exome Sequencing Project (http://evs.gs.washington.ed u/EVS/; dbSNP rs1801187). -

not provided Benign:3
Nov 21, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Apr 28, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Duchenne muscular dystrophy Benign:3
Aug 01, 2017
Phosphorus, Inc.
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dilated cardiomyopathy 3B Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Duchenne muscular dystrophy;C0878544:Cardiomyopathy;C0917713:Becker muscular dystrophy;na:Dystrophin deficiency Benign:1
Apr 20, 2017
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Cardiovascular phenotype Benign:1
Mar 11, 2015
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.079
BayesDel_addAF
Benign
-0.54
T
BayesDel_noAF
Benign
-0.40
CADD
Benign
23
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.32
.;T;.;.
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Uncertain
0.86
D;.;D;D
MetaRNN
Benign
0.000012
T;T;T;T
MetaSVM
Benign
-0.90
T
PhyloP100
4.2
PrimateAI
Uncertain
0.49
T
PROVEAN
Uncertain
-2.4
.;N;.;N
REVEL
Uncertain
0.31
Sift
Uncertain
0.0060
.;D;.;D
Sift4G
Uncertain
0.020
D;D;D;D
Polyphen
1.0
.;D;.;.
Vest4
0.15
MPC
0.071
ClinPred
0.020
T
GERP RS
5.2
gMVP
0.37
Mutation Taster
=93/7
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1801187; hg19: chrX-32380996; COSMIC: COSV63739824; COSMIC: COSV63739824; API